| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 92, 776-783, Copyright © 1986 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
SB Calderwood, LA Swinski, AW Karchmer, CM Waternaux and MJ Buckley
We analyzed the outcome of 116 patients with prosthetic valve endocarditis
treated between 1975 and 1983 and used multivariate analysis to identify
risk factors for in-hospital mortality and bad outcome during follow-up.
Complicated prosthetic valve endocarditis was defined as the presence of a
new or changing heart murmur, new or worsening heart failure, new or
progressive cardiac conduction abnormalities, or prolonged fever during
therapy. Complicated prosthetic valve endocarditis was present in 64% of
patients; factors associated with complicated prosthetic valve endocarditis
included aortic valve infection (odds ratio 4.3, p = 0.002) and onset of
endocarditis within 12 months of the cardiac operation (odds ratio 5.5, p =
0.0001). The in-hospital mortality rate for prosthetic valve endocarditis
was 23%; patients with complicated prosthetic valve endocarditis had a
higher mortality than patients with uncomplicated infection (odds ratio
6.4, p = 0.0009). Combined medical-surgical therapy was used in 39% of
patients; surgical therapy was more common in patients with complicated
prosthetic valve endocarditis (odds ratio 16, p less than 0.0001) and in
patients infected with coagulase- negative staphylococci (odds ratio 3.9, p
= 0.003). Survival after initially successful therapy for prosthetic valve
endocarditis was adversely affected by the presence of moderate or severe
congestive heart failure at hospital discharge (p = 0.03). Bad outcome
during follow-up (death, relapse of prosthetic valve endocarditis, or
subsequent cardiac operation related to sequelae of the original infection)
was more common in the medical than the medical-surgical therapy group (p =
0.02). The difference in long-term outcome between patients treated
initially with medical or with medical-surgical therapy was particularly
evident in those with complicated prosthetic valve endocarditis (p =
0.008). The presence of complicated prosthetic valve endocarditis is a
central variable in assessing prognosis and planning therapy; the majority
of patients with complicated prosthetic valve endocarditis are best treated
with medical-surgical therapy. Those who are not treated surgically during
their initial hospitalization are at high risk for progressive prosthesis
dysfunction and require careful follow-up.
ARTICLES
Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy
This article has been cited by other articles:
|
|
 |
|
  2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Stamou, G. Petterson, and A. M. Gillinov Surgical Treatment of Mitral Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 1069 - 1078. [Full Text]
|
|
|
|
 |
|
 S. Lopes, P. Calvinho, F. de Oliveira, and M. Antunes Allograft aortic root replacement in complex prosthetic endocarditis Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 126 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mahesh, G. Angelini, M. Caputo, X. Y. Jin, and A. Bryan Prosthetic Valve Endocarditis Ann. Thorac. Surg., September 1, 2005; 80(3): 1151 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rivas, J. Alonso, J. Moya, M. de Gorgolas, J. Martinell, and M. L. Fernandez Guerrero The Impact of Hospital-Acquired Infections on the Microbial Etiology and Prognosis of Late-Onset Prosthetic Valve Endocarditis Chest, August 1, 2005; 128(2): 764 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Habib, C Tribouilloy, F Thuny, R Giorgi, A Brahim, M Amazouz, J-P Remadi, G Nadji, J-P Casalta, F Coviaux, et al. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases Heart, July 1, 2005; 91(7): 954 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler Jr, A. F. Bolger, M. E. Levison, P. Ferrieri, M. A. Gerber, L. Y. Tani, M. H. Gewitz, et al. Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America Circulation, June 14, 2005; 111(23): e394 - e434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Kojic and R. O. Darouiche Candida Infections of Medical Devices Clin. Microbiol. Rev., April 1, 2004; 17(2): 255 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E F Akowuah, W Davies, S Oliver, J Stephens, I Riaz, P Zadik, and G Cooper Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment Heart, March 1, 2003; 89(3): 269 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Darouiche, V. G. Fowler Jr., K. Adal, M. Kielhofner, D. Mansouri, and L. B. Reller Antimicrobial Activity of Prosthetic Heart Valve Sewing Cuffs Coated With Minocycline and Rifampin Antimicrob. Agents Chemother., February 1, 2002; 46(2): 543 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.C. Yankah, H. Klose, R. Petzina, M. Musci, H. Siniawski, and R. Hetzer Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 260 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mylonakis and S. B. Calderwood Infective Endocarditis in Adults N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330. [Full Text] [PDF]
|
|
|
|
|
|
T. Mihaljevic, J. G. Byrne, L. H. Cohn, and S. F. Aranki Long-term results of multivalve surgery for infective multivalve endocarditis Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 842 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Gordon, J. M. Serkey, D. L. Longworth, B. W. Lytle, and D. M. Cosgrove III Early onset prosthetic valve endocarditis: the Cleveland Clinic Experience 1992-1997 Ann. Thorac. Surg., May 1, 2000; 69(5): 1388 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J C Castillo, M P Anguita, A Ramírez, J R Siles, F Torres, D Mesa, M Franco, I Muñoz, M Concha, and F Vallés Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study Heart, May 1, 2000; 83(5): 525 - 530. [Abstract] [Full Text]
|
|
|
|
|
|
K Truninger, C H A. Jost, B Seifert, P R Vogt, F Follath, A Schaffner, and R Jenni Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart, December 1, 1999; 82(6): 714 - 720. [Abstract] [Full Text]
|
|
|
|
|
|
S J D BRECKER, J R PEPPER, and S J EYKYN Aortic root abscess Heart, September 1, 1999; 82(3): 260 - 262. [Full Text] [PDF]
|
|
|
|
|
|
M.-B. Edwards, C. P. Ratnatunga, C. J. Dore, and K. M. Taylor Thirty-day mortality and long-term survival following surgery for prosthetic endocarditis: a study from the UK heart valve registry Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 156 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. d'Udekem, T. Sluysmans, and J. E. Rubay Tricuspid Valve Repair for Tricuspid Valve Endocarditis After Fallot Repair Ann. Thorac. Surg., March 1, 1997; 63(3): 830 - 832. [Abstract] [Full Text]
|
|
|
|
|
|
W. Vongpatanasin, L. D. Hillis, and R. A. Lange Prosthetic Heart Valves N. Engl. J. Med., August 8, 1996; 335(6): 407 - 416. [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Lytle, B. P. Priest, P. C. Taylor, F. D. Loop, S. K. Sapp, R. W. Stewart, P. M. McCarthy, D. Muehrcke, and D. M. Cosgrove III SURGICAL TREATMENT OF PROSTHETIC VALVE ENDOCARDITIS J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 198 - 210. [Abstract] [Full Text]
|
|
|
|
|
|
F. L. Grover, D. J. Cohen, C. Oprian, W. G. Henderson, G. Sethi, K. E. Hammermeister, and Participants in the Department of Veterans Affairs Determinants of the occurrence of and survival from prosthetic valve endocarditisExperience of the Veterans Affairs Cooperative Study on Valvular Heart Disease J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 207 - 214. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
